Your browser doesn't support javascript.
loading
Bone marrow failure and extramedullary hematopoiesis in McCune-Albright syndrome.
Robinson, C; Boyce, A M; Estrada, A; Kleiner, D E; Mathew, R; Stanton, R; Frangoul, H; Collins, M T.
Afiliação
  • Robinson C; Section on Skeletal Disorders and Mineral Homeostasis, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
  • Boyce AM; The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
  • Estrada A; Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.
  • Kleiner DE; Section on Skeletal Disorders and Mineral Homeostasis, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
  • Mathew R; Division of Endocrinology and Diabetes, Children's National Health System, Washington, DC, USA.
  • Stanton R; Bone Health Program, Division of Orthopaedics and Sports Medicine, Children's National Health System, Washington, DC, USA.
  • Frangoul H; Section on Skeletal Disorders and Mineral Homeostasis, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
  • Collins MT; Division of Endocrinology and Diabetes, Children's National Health System, Washington, DC, USA.
Osteoporos Int ; 29(1): 237-241, 2018 01.
Article em En | MEDLINE | ID: mdl-29071359
In fibrous dysplasia/McCune-Albright syndrome (FD/MAS), bone and bone marrow are, to varying degrees, replaced by fibro-osseous tissue typically devoid of hematopoietic marrow. Despite the extensive marrow replacement in severely affected patients, bone marrow failure is not commonly associated with FD/MAS. We present a 14-year-old girl with FD/MAS, who developed pancytopenia and extramedullary hematopoiesis (EMH) with no identified cause, in the setting of iatrogenic thyrotoxicosis and hyperparathyroidism. Pancytopenia, requiring monthly blood transfusions, persisted despite multiple strategies to correct these endocrinopathies. Due to worsening painful splenomegaly, likely as a result of sequestration, splenectomy was performed. Following splenectomy, pancytopenia resolved and patient has since been transfusion-independent. We report the first detailed case of bone marrow failure and EMH in FD/MAS. The etiology of marrow failure is likely multifactorial and related to the loss of marrow reserve due to extensive polyostotic FD, exacerbated by iatrogenic thyrotoxicosis and hyperparathyroidism. Mini Abstract: A patient with fibrous dysplasia developed bone marrow failure and extramedullary hematopoiesis. The etiology likely involved loss of hematopoetic marrow space and uncontrolled endocrinopathies. Splenectomy was therapeutic.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças da Medula Óssea / Hematopoese Extramedular / Displasia Fibrosa Poliostótica / Hemoglobinúria Paroxística / Anemia Aplástica Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Adolescent / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças da Medula Óssea / Hematopoese Extramedular / Displasia Fibrosa Poliostótica / Hemoglobinúria Paroxística / Anemia Aplástica Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Adolescent / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article